U.S. flag

An official website of the United States government

Format

Send to:

Choose Destination

Pupillary hypersensitivity to parasympathomimetic agents

MedGen UID:
1052816
Concept ID:
CN378345
Finding
HPO: HP:6000993

Definition

A higher than normal tendency of parasympathomimetic agents to induce miosis. [from HPO]

Term Hierarchy

CClinical test,  RResearch test,  OOMIM,  GGeneReviews,  VClinVar  
  • CROGVPupillary hypersensitivity to parasympathomimetic agents

Conditions with this feature

Familial dysautonomia
MedGen UID:
41678
Concept ID:
C0013364
Disease or Syndrome
Familial dysautonomia, which affects the development and survival of sensory, sympathetic, and parasympathetic neurons, is a debilitating disorder present from birth. Neuronal degeneration progresses throughout life. Affected individuals have gastrointestinal dysfunction, autonomic crises (i.e., hypertensive vomiting attacks), recurrent pneumonia, altered pain sensitivity, altered temperature perception, and blood pressure instability. Hypotonia contributes to delay in acquisition of motor milestones. Optic neuropathy results in progressive vision loss. Older individuals often have a broad-based and ataxic gait that deteriorates over time. Developmental delay / intellectual disability occur in about 21% of individuals. Life expectancy is decreased.

Recent clinical studies

Etiology

Clark CV, Mapstone R
Invest Ophthalmol Vis Sci 1987 Oct;28(10):1732-5. PMID: 3308761

Diagnosis

Stang J, Stensrud T, Mowinckel P, Carlsen KH
Med Sci Sports Exerc 2016 Nov;48(11):2100-2107. doi: 10.1249/MSS.0000000000001008. PMID: 27285494

Therapy

Clark CV, Mapstone R
Invest Ophthalmol Vis Sci 1987 Oct;28(10):1732-5. PMID: 3308761
Benjamin KW
Int Ophthalmol Clin 1979 Spring;19(1):199-255. doi: 10.1097/00004397-197901910-00011. PMID: 376469

Supplemental Content

Table of contents

    Clinical resources

    Consumer resources

    Recent activity

    Your browsing activity is empty.

    Activity recording is turned off.

    Turn recording back on

    See more...